about
A primer on tumour immunology and prostate cancer immunotherapyDNA vaccine encoding human papillomavirus antigens flanked by a signal peptide and a KDEL sequence induces a potent therapeutic antitumor effect.Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor.Micro- and nanoparticulates for DNA vaccine delivery.Construction of a fusion plasmid containing the PSCA gene and cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and its anti-tumor effect in an animal model of prostate cancer.Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studiesThe Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy.Clinical potential of electroporation for gene therapy and DNA vaccine delivery.Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns.Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer.Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.c-Src Suppresses Dendritic Cell Antitumor Activity via T Cell Ig and Mucin Protein-3 Receptor.Nucleoside Modified mRNA Vaccines for Infectious Diseases.Therapeutic Cancer Vaccines.TLR Agonists as Adjuvants for Cancer Vaccines.Towards personalized, tumour-specific, therapeutic vaccines for cancer.Enhanced synergistic anti-Lewis lung carcinoma effect of a DNA vaccine harboring a MUC1-VEGFR2 fusion gene used with GM-CSF as an adjuvant.Immunotherapy for Breast Cancer: Current and Future Strategies.Antibody response to HER2 extracellular domain and subdomains in mouse following DNA immunization.Trial watch: DNA-based vaccines for oncological indicationsA Review of DNA Vaccines Against Influenza
P2860
Q26765697-9C829702-B3A1-4819-B098-09D6D3445204Q33598307-933F93BB-83F8-4C28-B879-7E6D6557860FQ35890518-3F70F1B7-EF2B-43DA-8E81-3D645D1F51F0Q37107134-D2F49E5D-9348-482B-B59E-7DB8C1090BFBQ37384416-CA6F2189-24A4-47B0-ADC5-225F258FBC3BQ37494787-92975F0B-C9C0-4EA4-883F-D27F07DF545DQ37729321-5EE89B82-1466-4843-A7B4-1CAB608D33F1Q38636510-0FF82B91-88CF-4CBE-A56E-96B2D2CD525BQ38649517-BAD8D8B7-8918-45A5-8108-99D512C41B0CQ39038768-5882E3B7-315A-4AB6-8651-3145B7449A20Q39450802-8E370D0F-31E7-4F22-B838-EE320D52FB5DQ39579445-0B28B082-26F6-49A7-95DC-08489F8E5A0DQ40405926-C3A955A8-7BF1-496A-98AB-91C32EE25966Q40728648-AC7E66D0-5F2E-4385-9702-A316B70C412EQ41997055-D421DD2E-FF16-4A47-B0C4-62E25A53AEAEQ47789519-989A5B91-7133-4130-B218-AE5FD78064A8Q47860410-6C73EDB8-145B-4C20-909B-38327592A5E4Q52587066-CC68A9C8-8E8D-406C-A814-98FB5AB9A6C0Q54252199-96D55B85-765F-4C82-9346-6FFC08CAFC6CQ56893452-2BA84A19-467A-4C7B-AC15-11922A7331E9Q57094261-26F8A642-38D0-4D4B-878D-05E0193F0701
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
DNA vaccine for cancer immunotherapy
@ast
DNA vaccine for cancer immunotherapy
@en
DNA vaccine for cancer immunotherapy
@nl
type
label
DNA vaccine for cancer immunotherapy
@ast
DNA vaccine for cancer immunotherapy
@en
DNA vaccine for cancer immunotherapy
@nl
prefLabel
DNA vaccine for cancer immunotherapy
@ast
DNA vaccine for cancer immunotherapy
@en
DNA vaccine for cancer immunotherapy
@nl
P2093
P2860
P921
P3181
P1476
DNA vaccine for cancer immunotherapy
@en
P2093
Andrew Yang
Benjamin Yang
Chien-Fu Hung
Jessica Jeang
P2860
P304
P3181
P356
10.4161/21645515.2014.980686
P407
P5008
P577
2014-01-01T00:00:00Z